Zerion Pharma A/S elects Carl-Åke Carlsson as Chairman of the Board

ZERION's Dispersome® technology has proven to be very efficient in improving the solubility and bioavailability of small molecule drugs. ZERION has established partnerships with a significant number of large pharmaceutical companies that are exploiting the Dispersome® platform for both new chemical entities as well as currently marketed drugs. Some of these partnerships are now proceeding into the clinical phase. ZERION's Dispersome® technology has proven to be very efficient in improving the...

ZERION's Dispersome® technology has proven to be very efficient in improving the solubility and bioavailability of small molecule drugs. ZERION has established partnerships with a significant number of large pharmaceutical companies that are exploiting the Dispersome® platform for both new chemical entities as well as currently marketed drugs. Some of these partnerships are now proceeding into the clinical phase.

Before his tenure at Xellia, Mr. Carlsson held several leadership roles at Alpharma (NYSE:ALO). For a decade, he was integral to the top leadership, overseeing business within pharmaceutical retail, specialty institutional markets, and the extensive global B2B sectors. Mr. Carlsson is also serving at prominent board positions, including the biotech company Vectron Biosolutions and Lecka Alpha Trading LP.

About Zerion Pharma A/S 

ZERION develops its own proprietary drug formulations and offers its Dispersome® technology platform to established pharma companies as a means to solve their challenging drug solubility problems. By applying ZERION's technology, the solubility of poorly soluble compounds may be greatly enhanced, which improves their oral bioavailability and thereby therapeutic outcomes for the patients.  

ZERION was established in 2019 as a spin-out from the University of Copenhagen based on almost a decade of research. 

For more information, please visit www.zerion.eu or contact: 

Ole Wiborg, CEO, Mobile: +45 40 96 80 18, E-mail: info@zerion.eu 

The following files are available for download:

 

View original content:https://www.prnewswire.co.uk/news-releases/zerion-pharma-as-elects-carl-ake-carlsson-as-chairman-of-the-board-301937388.html